The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s poc hba1C testing market report forecasts the poc hba1C testing market size to grow to $1.25 Billion by 2027, with a CAGR (compound annual growth rate) of more than 10%.

Learn More On The Poc Hba1C Testing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/poc-hba1c-testing-global-market-report

Poc Hba1C Testing Market Size Forecast
The global poc hba1C testing market is expected to grow from $760.33 million in 2022 to $848.77 million in 2023 at a compound annual growth rate (CAGR) of 11.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The POC hba1c testing market size is expected to grow from $1.25 billion in 2027 at a CAGR of 10.3%.

North America held the largest poc hba1C testing market share, and Africa was the fastest-growing region in 2022.

Key Poc Hba1C Testing Market Driver ­– Increase In The Prevalence Of Diabetes
According to the report published by the International Diabetes Federation, a Belgium-based umbrella organization of over 230 national diabetes associations, in 2021, there are 463 million individuals living with diabetes around the world 2019 an increase to 537 million in 2021. Also, by the year 2030, the overall number of diabetics is expected to reach 643 million, and by 2045, it will reach 783 million. Therefore, the increasing prevalence of diabetes is driving the growth of the POC HbA1C testing market.

Request for A Sample Of The Global Poc Hba1C Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6833&type=smp

Key Poc Hba1C Testing Market Trend – Technological Advancement
Major players in the market are investing in developing advanced technologies to provide fast, accurate results in a short period thereby helping laboratories to manage the increase in demand for testing. For instance, Abbott, a US-based medical devices and health care company, introduced Afinion™ HbA1c Dx assay, an in vitro diagnostic test for the quantitative determination of HbA1c in human venous and capillary whole blood for use on the Afinion 2 Analyzer, and also Afinion AS100 Analyzer. The Afinion HbA1c Dx assay is the only rapid POC test cleared by the U.S. Food and Drug Administration (FDA) to assist healthcare professionals in diagnosing diabetes and also determining the patient’s risk of developing the disorder. The test provides reliable and accurate results of 1,2 glycatedhemoglobin in just three minutes, helping physicians to evaluate patients and enabling them to formulate individualized care plans during a single visit to the doctor`s office.

Poc Hba1C Testing Market Segment
1) By Type Of Product: Instruments, and Consumables
2) By Technology: Ion-Exchange HPLC, Enzymatic Assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Other Technologies
3) By End User: Hospitals, Physician Office/Outpatient Centre, Home Care, and Other End Users

Poc Hba1C Testing Market Major Players and Strategies
Major players in the poc hba1C testing market are Bio-Rad Laboratories, Inc., Siemens Healthineers AG, Menarini Group, F. Hoffmann-La Roche Ltd., and ARKRAY Inc.

In May 2020, EKF Diagnostics, a Germany-based in vitro diagnostics company has partnered with Tosoh Europe N.V. for an undisclosed amount. The three-year distribution agreement with Tosoh Europe N.V. is for the distribution of its Quo-Test HbA1c point-of-care (POC) analyzer in the Middle East and Africa. Tosoh Bioscience is a Japan-based chemical and specialty materials company.

The Poc Hba1C Testing Global Market Report 2023 covers regional data on poc hba1C testing market size, POC HbA1C testing market trends and drivers, opportunities, strategies, and poc hba1C testing market competitor analysis. The countries covered in the poc hba1C testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

POC HbA1C testing devices are designed to diagnose average levels of glucose in patients’ blood and to control type I and type II diabetes mellitus. Diabetes is a chronic disease that occurs either when an inadequate amount of insulin is produced by the pancreas or when the body cannot use the insulin it produces effectively. This assesses the average level of blood sugar over 2 to 3 months in an individual.

View More Reports Related To The Poc Hba1C Testing Market –
Noninvasive Prenatal Testing Global Market Report 2023
Rapid Microbiology Testing Kits Global Market Report 2023
Veterinary Laboratory Testing Services Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: